Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Blu2864 | 2810747-89-6 | 99.5% | 452.43 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY15007650MG

Encompass_Preferred

BLU2864 is an orally active, highly selective, and ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM. This compound demonstrates anti-tumor activity and is suitable for research related to cancer and polycystic kidney disease.

  • Highly selective, ATP-competitive PRKACA inhibitor
  • Exhibits anti-tumor activity
  • Supports cancer research
  • Supports polycystic kidney disease research
  • Inhibits forskolin-induced in vitro cystogenesis
  • Inhibits renal PKA activity
  • Ameliorates polycystic kidney disease
  • Reduces tumor growth in vivo

Catalog No. 50-003-61268


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.